Oxford University coronavirus vaccine safe, induces immune response: Scientists - Results show strong antibody and T-cell immune responses for up to 56 days after volunteers given the vaccine
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of the phase one clinical trial and results, published in the ‘Lancet’ medical journal.
The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given the vaccine. T-cells are crucial for maintaining protection against the virus for years.
The findings are seen as promising, but experts feel it is too soon to know if this is enough to offer protection as larger trials get under way.
“There is still much work to be done before we can confirm if our vaccine will help manage the COVID-19 pandemic, but these early results hold promise,” said Professor Sarah Gilbert, co-author of the study.